August 31st, according to news,
On August 30, 2026, the Chinese epichlorohydrin market maintained an overall oscillating trend, with a strong resistance to declines and a characteristic of mostly positive recovery. In the short term, prices are consolidating and volatility is narrowing, while medium- to long-term indicators have significantly improved, and the downward momentum continues to weaken. Price levels across multiple periods are diverging, with limited long-term downside space, and no clear unilateral market opportunities in the medium to short term. The overall market is mainly characterized by a consolidation with a slightly positive bias.
1. Mean Difference Change Table
| Indicator | Today’s Value (2026.8.30) | Yesterday’s Value (2026.8.29) | Direction of Change |
|---|---|---|---|
| 5-day Average Difference (D5) | 0.00 | 0.00 | Flat |
| 10-day Average Difference (D10) | 80.00 | 120.00 | - |
| 20-day Average Difference (D20) | -60.00 | -130.00 | + |
2. Signal Status Determination
Currently, the market is in a volatile phase characterized by an anti-downturn warning (leaning bullish). The key features include a significant rebound in the 20-day moving average difference over the medium to long term, a slight pullback in the 10-day moving average difference over the short term, and price stabilization over the past five days, with downward momentum noticeably narrowing.
3. Trend Direction Conclusion
The current price trend is fluctuating, as the direction of change in the 5-day, 10-day, and 20-day moving averages compared to the previous day is not entirely consistent, and does not meet the criteria for a clear upward or downward trend.
4. Positional Spatial Reference
The 1-year cycle price is in the second tier (mid-to-low range), and there is limited room for a prolonged decline.
Over a 60-day and 3-month period, prices are in the third tier (median), and there is currently no clear room for either unilateral upward or downward movement in the short to medium term.
5. Trend chart display
6. Risk Warning
The above analysis is for reference only and does not constitute trading advice.
